Jennison Associates’s Q32 Bio QTTB Stock Holding History

Jennison Associates’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,556	Closed	-$1.87M	–	716
2018 Q1	$1.87M	Buy	+5,556	New	+$1.87M	﹤0.01%	524

Other funds holding QTTB

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Jennison Associates's QTTB Position: Q2 2018 in Review

Jennison Associates sold out of Q32 Bio (QTTB) in Q2 2018, closing a stake of 5,556 shares — an estimated $1.87M sold.

Jennison Associates first reported a position in QTTB in Q1 2018 and held it in 1 quarter. The position peaked at $1.87M in Q1 2018. 53 funds tracked by Wall St. Rank hold QTTB as of Q2 2018.

Jennison Associates reported no remaining Q32 Bio position as of Q2 2018 after selling out during the quarter.
Jennison Associates sold 5,556 Q32 Bio shares in Q2 2018, an estimated $1.87M.
Jennison Associates first reported a position in Q32 Bio in Q1 2018 and held it in 1 quarter.
Jennison Associates's Q32 Bio position peaked at $1.87M in Q1 2018.
53 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2018.

Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.